Vitamin D, selenium, and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis

doi:10.4239/wjd.v15.i2.209

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4762)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

WORD

HTML

2560

Figures (1-2)

204

Tables (1-6)

208

Sum=3084

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

274

Download

491

Sum=765

Publishing Process of This Article

Item

Count

Browse

216

Download

533

Sum=749

Feb 15, 2024 (publication date) through Dec 21, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Diabetes. Feb 15, 2024; 15(2): 209-219
Published online Feb 15, 2024. doi: 10.4239/wjd.v15.i2.209

Open in New Tab Full Size Figure Download Figure

Figure 1 Comparison of serum 25-hydroxyvitamin D3 levels in the three groups pre-treatment and 3 and 6 months after treatment. ^dP < 0.0001. 25 (OH) D₃: 25-hydroxyvitamin D₃.

Open in New Tab Full Size Figure Download Figure

Figure 2 Comparison of autoantibody levels in the three groups pre-treatment and 3 and 6 months after treatment. A: Changes in thyroid peroxidase antibody level; B: Changes in thyroid globulin antibody level. ^bP < 0.01; ^cP < 0.001; ^dP < 0.0001. TPOAB: Thyroid peroxidase antibody; TGAB: Thyroid globulin antibody.

Citation: Feng F, Zhou B, Zhou CL, Huang P, Wang G, Yao K. Vitamin D, selenium, and antidiabetic drugs in the treatment of type 2 diabetes mellitus with Hashimoto's thyroiditis. World J Diabetes 2024; 15(2): 209-219
URL: https://www.wjgnet.com/1948-9358/full/v15/i2/209.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i2.209